Less than two weeks after denying reports that its Else mobile project was in trouble Israeli technology firm Emblaze has confirmed it is abandoning plans to manufacture the First ELSE mobile device.The company said it will concentrate its efforts on licensing the ELSE Intuition platform and technology in a move that will drastically reduce the company's operational and development costs.Digital security systems outfit SerVision swung into a full-year pre-tax profit $193,000 after a $1.06m loss last time after revenues increased by 13%."We remain hopeful of maintaining our progress through the remainder of 2010," the group said.Nestor Healthcare said the month on month growth in Social Care hours, which commenced in the second quarter of 2009, has continued in the first five months of 2010, while contract wins in Primary Care are establishing a solid base from which to grow profits.Events and conferencing group Tarsus said its business continues to perform with about three quarters of expected 2010 full year revenues now contracted.James Fisher has sold its Norwegian subsidiary ScanTech Eiendom (STE) to Dusavika Eiendomsinvest and its office and workshop facilities in Haugesund, Norway for a combined total of £18.5m.GW Pharmaceuticals and Otsuka Pharmaceutical have signed a three year extension to their global cannabinoid research programme, which will now run to the end of June 2013. The two firms are looking into potential new drug candidates in the field of Central Nervous System disorders and oncology.Byotrol has successfully completed its first order to Tink's, the largest supplier of hunting lures and scents in the US. The opening order, valued at $140,000, is for the supply of odour elimination products containing Byotrol patented technology. Homeland security specialist investor Blue Star Capital cut its losses to £390,000, compared to £1 .17m, in the six months to end March. Net assets were reduced £4.36m.Business software supplier Workplace Systems made a small pre-tax profit of £50,000 in the half year compared with a £2.36m loss. Alecto Energy has taken a 9.73% shareholding in AIM listed Charles Street Capital as part of it's strategy of building a portfolio of resource projects and investments in the natural resource sector.